Table 1 Correlations of BP1 and DLX7 expression with clinical characteristics and laboratory results of CML patients
Patient characteristic | BP1 expression | DLX7 expression | ||||
|---|---|---|---|---|---|---|
High (n = 25) | Low (n = 50) | P | Low (n = 39) | High (n = 36) | P | |
Sex, male/female | 16/9 | 33/17 | 1.000 | 26/13 | 23/13 | 0.813 |
Median age, years (range) | 54 (25–75) | 53.5 (15–83) | 0.698 | 48 (22–76) | 52.5 (15–67) | 0.150 |
Median WBC, × 109/L (range) | 65.3 (25.1–298.6) | 70.3 (20–412.8) | 0.348 | 73.1 (24.5–413.8) | 60.9 (21.7–321.9) | 0.627 |
Median hemoglobin, g/L (range) | 97 (70–134) | 92 (57–145) | 0.908 | 92 (57–145) | 96.5 (66–134) | 0.585 |
Median platelets, × 109/L (range) | 277 (16–1175) | 367 (40–1004) | 0.230 | 259 (40–1006) | 373.5 (16–1175) | 0.597 |
Cytogenetics | Â | Â | 0.227 | Â | Â | 0.975 |
 t(9;22) | 16 | 35 |  | 27 | 24 |  |
 t(9;22) with additional alteration | 5 | 3 |  | 4 | 4 |  |
 Normal karyotype | 2 | 3 |  | 2 | 3 |  |
 No data | 2 | 9 |  | 6 | 5 |  |
Staging | Â | Â | 0.602 | Â | Â | 0.008 |
 CP | 20 | 40 |  | 26 | 34 |  |
 AP | 1 | 5 |  | 5 | 1 |  |
 BC | 4 | 5 |  | 8 | 1 |  |
Median BCR/ABL transcript, % (range) | 164.1 (13.81–14,464.68) | 136.74 (16.87–3211) | 0.933 | 216.47 (16.87–3211.00) | 93.285 (13.81–14,464.68) | 0.054 |